Trawicki Roman 4
4 · Zoetis Inc. · Filed Mar 18, 2022
Insider Transaction Report
Form 4
Zoetis Inc.ZTS
Trawicki Roman
Executive Vice President
Transactions
- Exercise/Conversion
Common Stock
2022-03-16$87.51/sh+6,000$525,060→ 14,218 total - Sale
Common Stock
2022-03-16$188.15/sh−6,000$1,128,900→ 8,218 total - Exercise/Conversion
Stock Option
2022-03-16−6,000→ 33,941 total→ Common Stock (6,000 underlying)
Footnotes (6)
- [F1]The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.10 to $188.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
- [F3]6,000 options granted February 12, 2019 at an exercise price of $87.51 per option.
- [F4]Each option vests on the third anniversary of the date of grant.
- [F5]Each option expires on the tenth anniversary of the date of grant.
- [F6]7,774 options granted February 12, 2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; 9,254 options granted February 10, 2021 at an exercise price of $160.62 per option; and 7,332 options granted February 8, 2022 at an exercise price of $201.30 per option.